Company attributes
Industry
B2X
Pitchbook URL
Date Incorporated
2011
Spinout
Number of Employees (Ranges)
11 – 50
Email Address
info@entospharma.com?subject=General%20Inquiry
info@entospharma.com
Phone Number
+17808627445
Number of Employees
23
Full Address
Unit 4550 10230 Jasper Avenue Edmonton, Alberta T5J 4P6 Canada
CIK Number
Investors
Founded Date
2016
0Total Funding Amount (USD)
5,000,000
Latest Funding Round Date
May 22, 2025
Also Known As
Entos
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
1,000,000
Entos Pharmaceuticals Inc. is a Canada-based biotechnology company founded in 2006 and specializes in nanomedicines. It focuses on the use of its Fusogenix technology in the delivery of next-generation nucleic acid-based genetic therapies. It is also involved in COVID-19 researches that include a DNA vaccine and a drug for neutralizing antibodies.
Timeline
No Timeline data yet.
